Year-end Sale % OFF 
Abstract
[This corrects the article DOI: 10.1155/2019/6179573.].
Highlights
Corrigendum Corrigendum to “HDAC and HMT Inhibitors in Combination with Conventional Therapy: A Novel Treatment Option for Acute Promyelocytic Leukemia”
Correspondence should be addressed to Aida Vitkeviciene; aida.vitkeviciene@gmc.vu.lt
In the article titled “HDAC and HMT Inhibitors in Combination with Conventional erapy: A Novel Treatment Option for Acute Promyelocytic Leukemia” [1], the last author was mistakenly linked to the second affiliation instead of the first. e corrected author list and affiliations are shown above
Summary
Corrigendum Corrigendum to “HDAC and HMT Inhibitors in Combination with Conventional Therapy: A Novel Treatment Option for Acute Promyelocytic Leukemia”
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
